Adams Diversified Equity Fund’s Ligand Pharmaceuticals LGND Stock Holding History

Adams Diversified Equity Fund’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,488	Closed	-$380K	–	234
2018 Q4	$380K	Buy	4,488 +1,282	+40%	+$137K	0.02%	198
2018 Q3	$549K	Sell	3,206 -2,405	-43%	-$363K	0.03%	189
2018 Q2	$725K	Sell	5,611 -480	-8%	-$53.6K	0.04%	152
2018 Q1	$628K	Hold	6,091	–	–	0.03%	172
2017 Q4	$520K	Sell	6,091 -1,764	-22%	-$153K	0.03%	196
2017 Q3	$667K	Buy	+7,855	New	+$622K	0.04%	201
2016 Q4	–	Sell	-4,168	Closed	-$310K	–	234
2016 Q3	$310K	Hold	4,168	–	–	0.02%	178
2016 Q2	$310K	Buy	+4,168	New	+$309K	0.02%	178

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Adams Diversified Equity Fund's LGND Position: Q1 2019 in Review

Adams Diversified Equity Fund sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 4,488 shares — an estimated $380K sold.

Adams Diversified Equity Fund first reported a position in LGND in Q2 2016 and held it in 8 quarters. The position peaked at $725K in Q2 2018. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

Adams Diversified Equity Fund reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 4,488 Ligand Pharmaceuticals shares in Q1 2019, an estimated $380K.
Adams Diversified Equity Fund first reported a position in Ligand Pharmaceuticals in Q2 2016 and held it in 8 quarters.
Adams Diversified Equity Fund's Ligand Pharmaceuticals position peaked at $725K in Q2 2018.
330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2019, filed 26 Apr 2019.